The Japan Pharmaceutical Manufacturers Association (JPMA) is a voluntary association comprising of 72 research-oriented pharmaceutical companies (as of July 1, 2022). We are engaged with various initiatives, such as the solution of common issues in the pharmaceutical industry, activities to deepen the understanding of pharmaceuticals, and international collaboration across various industries.
In the Aging Group, members from pharmaceutical companies and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) have discussed issues related to aging, pharmaceutical company initiatives, possible countermeasures, and policy recommendations.
Executive Director of Sustainability Department, Eisai Co. Ltd., Patent Attorney.
After working in the intellectual property field, Yasuko Minamida worked in corporate strategy, public relations, investor relations, and environmental development for the launch of new treatments for Alzheimer's disease, before assuming her current position.